Labocanna Sa Zy 10 Stock EBITDA
| 9Y2 Stock | EUR 0.05 0.0006 1.12% |
LABOCANNA SA ZY 10 fundamentals help investors to digest information that contributes to LABOCANNA's financial success or failures. It also enables traders to predict the movement of LABOCANNA Stock. The fundamental analysis module provides a way to measure LABOCANNA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LABOCANNA stock.
LABOCANNA |
LABOCANNA SA ZY 10 Company EBITDA Analysis
LABOCANNA's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, LABOCANNA SA ZY 10 reported earnings before interest,tax, depreciation and amortization of 0.0. This is 100.0% lower than that of the Industrials sector and about the same as Specialty Business Services (which currently averages 0.0) industry. The ebitda for all Germany stocks is 100.0% higher than that of the company.
LABOCANNA EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LABOCANNA's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LABOCANNA could also be used in its relative valuation, which is a method of valuing LABOCANNA by comparing valuation metrics of similar companies.LABOCANNA is currently under evaluation in ebitda category among its peers.
LABOCANNA Fundamentals
| Return On Equity | 82.13 | |||
| Return On Asset | 6.13 | |||
| Profit Margin | 119.42 % | |||
| Current Valuation | 5.16 M | |||
| Shares Outstanding | 7.65 M | |||
| Gross Profit | 40 K | |||
| Current Ratio | 0.49 X | |||
| Beta | 3.1 | |||
| Market Capitalization | 4.34 M |
About LABOCANNA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LABOCANNA SA ZY 10's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LABOCANNA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LABOCANNA SA ZY 10 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in LABOCANNA Stock
LABOCANNA financial ratios help investors to determine whether LABOCANNA Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LABOCANNA with respect to the benefits of owning LABOCANNA security.